Feedback / Questions
EVOLVE-104 - EvolveImmune Therap
https://www.globenewswire.com/news-release/2025/12/16/3206091/0/en/EvolveImmune-Therapeutics-Announces-Initiation-of-Dosing-in-a-Phase-1-Trial-of-EVOLVE104-in-Patients-with-Solid-Tumors.html
Dec 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next